🇺🇸 FDA
Pipeline program

ZYNRELEF 200Mg-6Mg Extended-Release Solution

Heron Holyoke 1

Approved small_molecule active

Quick answer

ZYNRELEF 200Mg-6Mg Extended-Release Solution for Post Operative Pain, Acute is a Approved program (small_molecule) at HERON THERAPEUTICS, INC. /DE/ with 1 ClinicalTrials.gov record(s).

Program details

Company
HERON THERAPEUTICS, INC. /DE/
Indication
Post Operative Pain, Acute
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials